Mycophenolate mofetil and Pneumatosis intestinalis - a phase IV clinical study of FDA data
Summary:
We study 84,384 people who have side effects when taking Mycophenolate mofetil. Pneumatosis intestinalis is found, especially among people who are male, 2-9 old, have been taking the drug for < 1 month, also take Tacrolimus and have Immunodeficiency disorders.
The phase IV clinical study analyzes which people take Mycophenolate mofetil and have Pneumatosis intestinalis. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
84,384 people reported to have side effects when taking Mycophenolate mofetil.
Among them, 249 people (0.3%) have Pneumatosis intestinalis.
What is Mycophenolate mofetil?
Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is used in myasthenia gravis. Currently, eHealthMe is studying from 84,655 Mycophenolate mofetil users.
What is Pneumatosis intestinalis?
Pneumatosis intestinalis (air or gas in an intestine) is found to be associated with 573 drugs and 465 conditions by eHealthMe. Currently, we are studying 2,869 people who have Pneumatosis intestinalis.
Number of Mycophenolate mofetil and Pneumatosis intestinalis reports submitted per year:
Time on Mycophenolate mofetil when people have Pneumatosis intestinalis *:
Gender of people who have Pneumatosis intestinalis when taking Mycophenolate mofetil*:
Age of people who have Pneumatosis intestinalis when taking Mycophenolate mofetil *:
Common drugs people take besides Mycophenolate mofetil *:
Common side effects people have besides Pneumatosis intestinalis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Mycophenolate mofetil and have Pneumatosis intestinalis?
Check whether Pneumatosis intestinalis is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- O'rafferty C, McElligott F, Storey L, O'marcaigh A, Smith O, "Pneumatosis intestinalis and imatinib mesylate", Annals of hematology, 2014 Oct .
Related studies
Mycophenolate mofetil side effects by duration, gender and age:
- Mycophenolate mofetil side effects (84,655 reports)
Pneumatosis intestinalis treatments and more:
- Pneumatosis intestinalis (2,869 reports)
Common drugs associated with Pneumatosis intestinalis:
- Prednisolone: 359 reports
- Prednisone: 342 reports
- Tacrolimus: 322 reports
- Methotrexate: 300 reports
- Cyclophosphamide: 294 reports
- Mycophenolate mofetil: 249 reports
- Etoposide: 197 reports
- Cytarabine: 193 reports
- Fluorouracil: 164 reports
- Vincristine sulfate: 159 reports
All the drugs that are associated with Pneumatosis intestinalis:
- Pneumatosis intestinalis (573 drugs)
Common conditions associated with Pneumatosis intestinalis:
- Acute lymphocytic leukemia (all): 232 reports
All the conditions that are associated with Pneumatosis intestinalis:
- Pneumatosis intestinalis (465 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Mycophenolate mofetil) and Mycophenolate mofetil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Gabapentin and Relapsing-Remitting Multiple Sclerosis - 11 seconds ago
- Ramipril and Caspofungin Acetate drug interaction - 14 seconds ago
- Prograf and Rapamune drug interaction - 36 seconds ago
- Everolimus and Skin Toxicity - 38 seconds ago
- Trazodone Hydrochloride and Erlotinib Hydrochloride drug interaction - 38 seconds ago
- Dapagliflozin and Diabetic Ketoacidosis - 43 seconds ago
- Zoloft and Lung Infection - 46 seconds ago
- Replavite and Piperacillin And Tazobactam drug interaction - 56 seconds ago
- Aspirin and Escherichia Sepsis - a minute ago
- Prednisone and Respiratory Failure (Excl Neonatal) - a minute ago